ACM CLINICAL LIMITED
🌿Early-stageactive
14813419 · ltd · incorporated 2023-04-19
Investment thesis
Growth-phase business — story-led; valuation sensitive to momentum.
Why interesting: Trading is scaling; acquirers paying for trajectory get disproportionate leverage.
Why risky: Price often leads fundamentals; dependency on founder often high.
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Mar 2025
Net worth
—
book net assets
Opportunity
70/100
Strong
What this business does
Primary activity: Specialist medical practice activities
Sector: Human health & social work
Investor take
PursueStrong opportunity: active trading company with strong profile and acceptable with review structure.
Opportunity 70/100 (strong), bankability 70/100. Share purchase looks the cleaner deal structure. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
1 active PSC(s) of 1 total, 1 with control declared
90
Director network
Network not yet resolved
30
Filing history
14 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
70/100Strong
PassWatchWorth a lookStrongExceptional
Solid opportunity signal. Worth a dedicated memo and management meeting.
Business quality
60
Adequate — check latest filings for context.
Acquirability
50
Some acquirability indicators.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.
Key financials
2 years extracted from filed iXBRL accountsCash
—
Net Worth
—
Current Assets
—
Current Liabilities
—
Hover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Average employees | 0 | 0 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
🔒Filing-note intelligence
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Last 30 days
0
filings
Last 90 days
1
filing
- • 1 confirmation-statement
Last 180 days
2
filings
- • 1 confirmation-statement
- • 1 accounts
Counts from Companies House filing history.
Corporate timeline (14 events)Click to expand
- 2025-12-22📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-05-13📄change-person-director-company-with-change-dateofficers · CH01
- 2025-03-20📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-03-19📄capital-allotment-sharescapital · SH01
- 2025-01-09📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-01-02📄resolutionresolution · RESOLUTIONS
- 2025-01-02📄memorandum-articlesincorporation · MA
- 2024-12-28📄capital-name-of-class-of-sharescapital · SH08
- 2024-12-28📄capital-variation-of-rights-attached-to-sharescapital · SH10
- 2024-10-28📄change-account-reference-date-company-previous-shortenedaccounts · AA01
- 2024-10-22➕CONWAY-MORRIS, Andrew Roderick, Dr appointeddirector
- 2023-04-19🏢Company incorporatedAs ACM CLINICAL LIMITED
- 2023-04-19➕CONWAY MORRIS, Anke, Dr appointeddirector
- 2023-04-19📄incorporation-companyincorporation · NEWINC
Owner dependency
58/100
Moderate — manageable with handoverSome founder dependency, but not acute. A structured handover period should cover most risk.
FACTORS
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
Succession & seller-readiness
36/100
Weak signalLimited succession signal. Not a near-term off-market candidate.
SIGNALS
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanNo red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
Shareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Anke Conway Morris Individual · British · DOB 07/1977 · age 49 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 19/04/2023 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · CB postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 3ROI SOLUTIONS LIMITED→ 14279170 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AACB CARE LIMITED→ 10864400 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ABDELHAK LIMITED→ 15969772 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ABDELLAH'S LIMITED→ 15003858 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ABRB CONSULTING LIMITED→ 16783643 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ACADEMY OF DIGITAL DENTISTRY LIMITED→ 09209732 · est 2014 · no financials extracted | — | — | — | — | 11y | — | — |
| ACCESS INDEPENDENT LTD→ 04664905 · est 2003 · no financials extracted | — | — | — | — | 23y | — | — |
| ACCUPHARM LIMITED→ 15432229 · est 2024 · no financials extracted | — | — | — | — | 2y | — | — |
| ACCURO (CARE SERVICES)→ 04507249 · est 2002 · no financials extracted | — | — | — | — | 23y | — | — |
| ACESO BIOSCIENCES LIMITED→ 13848700 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ACME ANAESTHETICS LIMITED→ 16399297 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| AD ASTRA MEDICAL CONSULTANCY LIMITED→ 11475349 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →🔒Advanced scoring suite
Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Statusactive
Typeltd
Incorporated2023-04-19
Jurisdictionengland-wales
Primary SIC86220 — Specialist medical practice activities
Registered office
5 High Green
Great Shelford
Cambridge
Cambridgeshire
CB22 5EG
England
Filing status
Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2027-05-02
Last: 2026-04-18
Officers (2 active · 0 resigned)
CONWAY MORRIS, Anke, Dr→
Activedirector · ~49y · appointed 2023-04-19
View their other companies + combined net worth →
CONWAY-MORRIS, Andrew Roderick, Dr→
Activedirector · ~48y · appointed 2024-10-22
View their other companies + combined net worth →
Click a director name to see their full track record across all companies.
Recent filings (14 total)
confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-04-30
accounts-with-accounts-type-micro-entity
accounts · AA
2025-12-22
confirmation-statement-with-updates
confirmation-statement · CS01
2025-05-13
change-person-director-company-with-change-date
officers · CH01
2025-05-13
appoint-person-director-company-with-name-date
officers · AP01
2025-03-20
capital-allotment-shares
capital · SH01
2025-03-19
accounts-with-accounts-type-micro-entity
accounts · AA
2025-01-09
resolution
resolution · RESOLUTIONS
2025-01-02
memorandum-articles
incorporation · MA
2025-01-02
capital-name-of-class-of-shares
capital · SH08
2024-12-28
capital-variation-of-rights-attached-to-shares
capital · SH10
2024-12-28
change-account-reference-date-company-previous-shortened
accounts · AA01
2024-10-28
confirmation-statement-with-updates
confirmation-statement · CS01
2024-04-29
incorporation-company
incorporation · NEWINC
2023-04-19